US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 36.170
  • +0.010+0.03%
Close Dec 13 16:00 ET
  • 36.170
  • 0.0000.00%
Post 17:48 ET
2.00BMarket Cap33.90P/E (TTM)

About Supernus Pharmaceuticals Company

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Company Profile

SymbolSUPN
Company NameSupernus Pharmaceuticals
Listing DateMay 1, 2012
Issue Price5.00
Founded2005
CEOMr. Jack A. Khattar
MarketNASDAQ
Employees652
Fiscal Year Ends12-31
Address9715 Key West Avenue
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-301-838-2500
Websitehttp://www.supernus.com

Company Executives

  • Name
  • Position
  • Salary
  • Jack A. Khattar
  • Director, President, Chief Executive Officer and Secretary
  • 13.28M
  • Dr. Jonathan Rubin, M.B.A.,M.D.
  • Senior Vice President, Research and Development and Chief Medical Officer
  • 1.59M
  • Timothy C. Dec
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • 2.38M
  • Padmanabh P. Bhatt
  • Senior Vice President, Intellectual Property and Chief Scientific Officer
  • 1.47M
  • Frank Mottola
  • Senior Vice President, Quality, GMP Operations and Information Technology
  • 1.79M
  • Tami Tillotson Martin, Esq.,R.N.
  • Senior Vice President, Regulatory Affairs
  • --
  • Charles W. Newhall, III
  • Chairman of the Board
  • 407.02K
  • Dr. Georges Gemayel,PhD
  • Independent Director
  • 378.52K
  • Frederick M. Hudson
  • Independent Director
  • 385.02K
  • Dr. Carrolee Barlow, M.D.,PhD
  • Independent Director
  • 376.02K
  • Bethany Sensenig
  • Independent Director
  • 514.39K
Heat List
US
Overall
Symbol
Price
% Chg

No Data